Medicine pack check sheet

Source-linked reading points

• 2.5, 5, 7.5, 10, 15 and 20 mg are stated amounts per regular tablet in the current label, not an answer to ‘how many tablets today.’ The image on this page is only for 10 mg, NDC 61269-633-30, a 30-tablet bottle; a matching name, colour or mg marking does not establish that another pack is the same product.
• ZYPREXA ZYDIS is an orally disintegrating tablet, ZYPREXA IntraMuscular is an intramuscular injection, and ZYPREXA RELPREVV is a separate long-acting injection. Do not self-change form, combine, alternate, replace tablets with an injection or infer splitting from package numbers merely because they share olanzapine or the ZYPREXA brand family; have the actual prescription and current label reviewed by the prescribing team or pharmacist.
• The U.S. label carries an important limitation for elderly people with dementia-related psychosis: ZYPREXA is not approved for that population. This is a label-reading prompt, not a web diagnosis or treatment conclusion for any person; with older age, cognitive change, falls, fainting, drowsiness or multiple medicines, ask the local care team to review every medicine and actual pack promptly.
• The label identifies co-medication review cues including medicines that can affect blood pressure, levodopa/dopamine agonists, and lorazepam in a specific intramuscular context. They do not let a website decide whether a person can use them together, how to separate them, or how to change or replace anything; take the complete medicine list and actual packs to a pharmacist or clinician for item-by-item review.